Endocannabinoid and exercise by Rajala, Eveliina
         
 
 
 
 
 
 
 
 
 
ENDOCANNABINOIDS AND EXERCISE  
 
 
 
 
 
 
 
 
 
 
 
 Eveliina Rajala  
Pro gradu -tutkielma 
Liikuntalääketiede 
Itä-Suomen yliopisto  
Lääketieteen laitos  
Toukokuu 2015 
 
 
 
  
UNIVERSITY OF EASTERN FINLAND, Faculty of Health Sciences  
School of Medicine 
Exercise Medicine 
RAJALA, EVELIINA : Endocannabinoids and exercise 
Master’s thesis, 45pages 
Supervisors: PhD Mika Venojärvi, professor Heikki Tikkanen 
May 2015 
Keywords: endocannabinoids, exercise, intensity, performance 
Humans have reported a wide range of neurobiological rewards such as sense of well-
being, anxiety reduction, calmness and reduced pain sensation following moderate and 
intense aerobic activity. These rewards have referred as “runners high” in research 
literature and may encourage to habitual aerobic exercise. Recent studies have 
supported a strong role for endocannabinoid signaling related to the neurobiological 
mechanisms behind these rewards.  
The aim of this study was to compile a systematic literature review of endocannabinoids  
and exercise from the viewpoint of previous human and animal researches related to 
subject in order to assess how exercise effects or activates endocannabinoid system in 
both research cohort. To be included in this systematic literature review studies had to 
have own described exercise protocols (human researches) or test models (animal 
researches) in order to make comparison between methods and results. Sixteen articles 
met the inclusion criteria and were reviewed.  
Most of the studies reviewed indicted that levels of endocannabinoid anandamide 
(AEA) increased statistically significantly during exercise regardless of exercise 
protocol or method. However levels of endocannabinoid 2-arachidonoylglycerol (2-AG) 
showed no remarkable changes after exercise. Human researches revealed that exercises 
in any given intensity increase circulating endocannabinoid (eCB) levels but moderate 
exercise intensities lead to most significant changes in the levels of AEA. Furthermore 
physical exercise in combination with high altitude enhances activation of the 
endocannabinoid system.  
Animal researches suggested that lacking of CB1-receptor reduced physical activity. 
Whereas administered antagonist mimicked the impact of missing CB1 receptor 
reducing running activity. It was also stated that endocannabinoid transmission had a 
crucial role in the protective effects against the motor and synaptic consequences of 
stress. In addition CB1 signalling between male and female HR (high runner) as well as 
obese rats compared with lean rats differ from one another with lower response rates 
with male and obese subjects. Further exercise in adolescence period significantly 
reduced the CB1 receptor expression in hippocampus. Finally cross sectional studies of 
human and animal research stated that cursorial mammals in general show significant 
increase in AEA levels following exercise as non-cursorial mammals showed no change 
This systematic review states that exercise activates the endocannabinoid system in 
humans and other mammals suggesting endocannabinoids are partly responsible for the 
reported improvements in mood and affect following aerobic exercise and may have 
important peripheral effects that likely aid exercise performance. 
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Ihmiset ovat raportoineet monimuotoisista neurobiologisista palkkioista, kuten hyvän 
olon tunteesta, levottomuuden vähenemistä, rauhallisuudesta sekä kivun lievenemisestä, 
jotka ilmenevät kohtuukuormitteisen tai intensiivisen aerobisen liikunnan jälkeen. 
Näihin palkintoihin on viitattu tutkimuskirjallisuudessa  termillä ”runners high” ja ne 
voivat osaltaan lisätä liikunta-aktiivisuutta. Viimeaikaiset tutkimukset ovat vahvasti 
osoittaneet, että nämä palkkiot linkittyvät endokannabinoideihin ja niihin liittyviin 
neurobiologisiin mekanismeihin. Tämän tutkimukset tavoitteena oli koota 
systemaattinen kirjallisuuskatsaus aiemmin aihepiiriin toteutettujen ihmis- ja eläin 
tutkimusten pohjalta, jotta voitiin arvioida kuinka liikunta vaikuttaa endokannabinoidi 
järjestelmään molemmissa tutkimus kohorteissa. Jotta aiempi tutkimus sisällytettiin 
tähän kirjallisuuskatsaukseen oli, sillä oltava oma kuvattu liikuntaohjelma 
(ihmistutkimukset) tai koeasetelma (eläintutkimukset). Näin ollen metodit ja tulokset 
olivat keskenään vertailukelpoisia. Yhteensä kuusitoista artikkelia vastasi valittuja 
kriteerejä ja otettiin tarkasteluun.   
 
Useimmat tarkastellut tutkimukset osoittivat, että aerobinen liikunta nosti tilastollisesti 
merkitsevästi endokannabinoidi anandamidi (AEA) tasoja liikunnan aikana riippumatta 
liikuntaohjelmasta tai metodista. Toisaalta endokannabinoidi 2-arachidonoylglyseroli 
(2-AG) tasot eivät osoittaneet vastaavaa nousua liikunnan jälkeen. Ihmistutkimukset 
paljastivat, että liikunta kaikilla intensiteeteillä nosti endokannabinoidi tasoja, mutta 
keskiraskas/kohtalainen intensiteetti johtivat merkitsevimpiin muutoksiin AEA-tasoissa 
kuin muu liikunta. Lisäksi ihmistutkimuksista selvisi, että liikunta korkeassa ilma-alassa 
parantaa endokannabinoidi-järjestelmän aktivoitumista.  
 
Eläintutkimukset paljastivat, että kannabinoidi 1 (CB1)-reseptorien puuttuminen 
vähentää liikunta-aktiivisuutta. Myös antagonistit (lääkeaineet) jäljittelevät puuttuvaa 
CB1-reseptoria vähentäen liikunta-aktiivisuutta. Lisäksi endokannabinoidien 
aktivoituminen suojaa merkittävästi stressin motoristen ja synaptisen oireiden synnyssä. 
Tutkimuksissa myös selvisi, että CB1 signalointi uros ja naaras (high runner) hiirten 
sekä ylipainoisten ja normaalipainoisten hiirten välillä poikkeavat toisistaan siten, että 
uros hiirten sekä ylipainoisten hiirten  signalointi on heikompaa. Lisäksi 
liikuntaharjoittelu nuoruusiässä voi laskea CB1-reseptorien määrää hippokampuksessa. 
Lopuksi poikkileikkaus tutkimus ihmisten ja eläinten välillä paljastivat, että 
cursoriaarisilla nisäkkäillä yleisesti AEA-tasot nousevat liikunnan aikana kun taas ei-
cursoorisilla nisäkkäillä tätä nousua ei tapahdu.  
 
Tämän systemaattisen kirjallisuuskatsauksen perustella voidaan todeta, että liikunta 
aktivoi endokannabinoidi järjestelmän ihmisillä sekä muilla nisäkkäillä osoittaen 
endokannabinoidien olevan osittain vastuussa kuvatuista liikunnan jälkeisistä 
neurobiologista palkinnoista, minkä vuoksi endokannabinoideilla voi olla merkittävä 
vaikutus liikunnan mielekkyyteen, suorituskykyyn ja vaikuttavuuteen. 
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ABBREVIATION 
 
2-AG   2-arachidonoylglycerol   
5-HT   5- hydroxytryptamine, serotonin 
AC   adenylyl cyclase 
Anandamid  N-arachidonoylethanolamine 
CB1    cannabinoid receptor 1  
CB2    cannabinoid receptor 2 
FAAH  fatty acid amide hydrolase 
GABA  gamma-aminobutyric acid 
HU-210  CB1/CB2-agonisti IBD inflammatory bowel disease 
NAPE   N-arachidonoyl phosphatidylethanolamide,  
NAT   N-acetyltransferase 
SR141716A  CB1-antagonist, rimonabant 
THC   delta-9-tetrahydrocannabinol 
VR1   vanilloid receptor 1 
WIN55212-2  CB1/CB2-agonist 
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1 INTRODUCTION 
 
Humans report a wide range of neurobiological rewards following moderate and intense 
aerobic activity (Raichlen et al. 2011) that includes both central effects (improved affect, sense 
of well-being, anxiety reduction, post-exercise calm) and peripheral effects (reduced pain 
sensation) (Raichlen et al. 2012), which may contribute to encourage habitual aerobic exercise 
(Raichlen et al. 2011). In the late 1960s, these changes associated with prolonged physical 
activity were often described as a ‘‘second wind.’ Nowdays a more contemporary label and 
popularly referred to as the ʻrunnerʼs highʼ (Dietrich and McDaniel 2004, Raichlen et al. 
2011). 
 
Recent work in humans and animal models has supported a strong role for endocannabinoid 
(eCB) signalling in the rewards associated with endurance exercise (Dietrich and McDaniel, 
2004) and behind the neurobiological mechanisms that may be responsible for the runner’s 
high (Raichlen et al. 2011). ECBs are endogenous neurotransmitters and ligands for the CB1 
and CB2 cannabinoid receptors, which were originally identified as the receptors activated 
THC, the principal psychoactive ingredient in marijuana. CB1 receptors are found in 
numerous brain areas, but are particularly dense in regions associated with emotion, cognition, 
motor behaviour, and reward. The two most studied eCBs, anandamide (AEA) and 2-
arachidonylglycerol (2-AG), are released by neurons both centrally and peripherally in an 
activity-dependent manner to modulate synaptic activity and plasticity such as the release of 
classical neurotransmitters (Raichlen et al. 2012).  
 
Before the discovery of strong role for endocannabinoid (eCB) signalling in the exercise-
induced rewards, such as analgesic effects, were often described as being a direct consequence 
of alterations in endogenous opioids, endorphins, release. These polypeptides are produced by 
central nervous system and pituitary gland. The serious problems with the “endorphin 
hypothesis” is that endorphins are too large to cross the blood-brain barrier, peripheral 
activation in the systemic circulation cannot be taken as indicative of central effects. Unlike 
endocannabinoids such as anandamide are lipids and can cross the blood-brain barrier readily, 
because of its highly lipophilic properties, systemic increases in anandamide concentrations 
are generally assumed to produce central effects. This fact avoids one of the principal 
problems that plagued the endorphin hypothesis of exercise induced analgesia.  
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This study is to compile a systematic literature review of endocannabinoids and exercise from 
the viewpoint of recent human and animal researches. Purpose of this systematic literature 
review is to assess how exercise with different variables effects may activate§ 
endocannabinoid system in order to have a richer concept of this phenomena.
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2 EXERCISE 
 
Studies explored in this review are divided into human researches and animal researches due 
to this it is essential to create a certain baseline of knowledge in order to comprehend research 
methods and measurements of studies reviewed. In both study lines there are specific 
measurement methods for exercise engendering comparable results and findings.  
2.1 Exercise in human researches 
 
Physical exercises are generally grouped into three types, depending on the overall effect they 
have on the human body. Aerobic activity is any physical activity that uses large muscle 
groups and causes the body to use more oxygen than it would while resting. Resistance 
training—also called strength training can firm, strengthen, and tone muscles, as well as 
improve bone strength, balance, and coordination. Flexibility exercises stretch and lengthen 
muscles. These activities help to improve joint flexibility and keep muscles limber, thereby 
preventing injury (National Institutes of Health 2006). 
 
Stimulating structural and functional adaptations to improve performance in specific physical 
task remains a major objective of exercise training. Proper training response is achieved by 
manipulating intensity, frequency and duration of exercise mode. Specific exercise elicits 
specific adaptations to promote specific training effects. All individuals do not respond 
similarly to a given training stimulus and optimal training benefits occur when exercise 
programs focus on individual needs and capacities of participants. However even among 
former highly trained athletes, the beneficial effects of many years of previous training remain 
transient and reversible (Bouchard 2007). 
 
Exercise is commonly described through training intensity and endurance. First factor 
(intensity) represent the response of exercise whereas second factors (endurance) figures 
duration of exercise instead (Bouchard 2007). 
 
General practice establishes aerobic training intensity via direct measurement (or estimation) 
of VO2max (maximal oxygen consumption or HRmax (maximal heart rate) and then assigns an 
exercise level to correspond to some percentage of maximum (Table 1). Establishing training 
intensity from measures of oxygen consumption provides a high degree of accuracy, but its 
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use requires sophisticated monitoring that renders this method impractical for general use. An 
effective alternative relies on heart rate to classify exercise for realtive intensity when 
individualizing training programs. Exercise heart rate is convenient because %VO2max and 
%HRmax relate in a predictable way regardless of gender, race, fitness level, exercise mode or 
age (Bouchard 2007). 
 
 
TABLE 1. Realtionship between percentage maximal heart rate and percentage VO2max 
(Bouchard 2007). 
Percentage HRmax Percentage VO2max 
50 28 
60 40 
70 58 
80 70 
90 83 
100 100 
 
 
Endurance can be divided to many forms from which most generally used is general aerobic 
and dynamic endurance. Most commonly criteria for aerobic and dynamic endurance is 
VO2max as described above. It is reduced in passive non-athlete persons after the age of 30 
proximately 8-10 % per decade. This is caused by ageing which decreases maximal heart rate 
and maximal capacity of heart (Table 2; Table 3). Endurance can be also linked to muscle 
strength that is on its maximum at age of 25-35. However the most significant drop in 
endurance and muscle strength occurs after 50 years (Vuori et al. 2004). 
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TABLE 2. Classification of endurance using percentage of maximum heart rate (VO2max 
ml/kg/min) – Women (Schwartz et al. 1990) 	   1	   2	   3	   4	   5	   6	   7	  Age/Fitness	  level	   Very	  Poor	   Poor	   Fair	  	   Avarage	   Good	  	   Excelent	  	   Superior	  20-­‐24	   <	  27	   27–31	   32–36	   37–41	   42–46	   47–51	   >	  51	  25-­‐29	   <26	   26–30	   31–35	   36–40	   41–44	   45–49	   >	  49	  30-­‐34	   <25	   25–29	   30–33	   34–37	   38–42	   43–46	   >	  46	  35-­‐39	   <24	   24–27	   28–31	   32–35	   36–40	   41–44	   >	  44	  40-­‐44	   <22	   22–25	   26–29	   30–33	   34–37	   38–41	   >	  41	  45-­‐49	   <21	   21–23	   24–27	   28–31	   32–35	   36–38	   >	  38	  50-­‐54	   <19	   19–22	   23–25	   26–29	   30–32	   33–36	   >	  36	  55-­‐59	   <18	   18–20	   21–23	   24–27	   28–30	   31–33	   >	  33	  60-­‐65	   <16	   16–18	   19–21	   22–24	   25–27	   28–30	   >	  30	  
 
TABLE 3. Classification of endurance using percentage of maximum heart rate (VO2max 
ml/kg/min) – Men (Schwartz et al. 1990) 	   1	   2	   3	   4	   5	   6	   7	  Age/Fitness	  level	   Very	  Poor	   Poor	   Fair	  	   Avarage	   Good	  	   Excelent	  	   Superior	  20-­‐24	   <	  32	   32–37	   38–43	   44–50	   51–56	   57–62	   >	  62	  25-­‐29	   <31	   31–35	   36–42	   43–48	   49–53	   54–59	   >	  59	  30-­‐34	   <29	   29–34	   35–40	   41–45	   46–51	   52–56	   >	  56	  35-­‐39	   <28	   28–32	   33–38	   39–43	   44–48	   49–54	   >	  54	  40-­‐44	   <26	   26–31	   32–35	   36–41	   42–46	   47–51	   >	  51	  45-­‐49	   <25	   25–29	   30–34	   35–39	   40–43	   44–48	   >	  48	  50-­‐54	   <24	   24–27	   28–32	   33–36	   37–41	   42–46	   >	  46	  55-­‐59	   <22	   22–26	   27–30	   31–34	   35–39	   40–43	   >	  43	  60-­‐65	   <21	   21–24	   25–28	   29–32	   33–36	   37–40	   >	  40	  
 
 
. 
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2.2 Exercise in animal researches  
 
Exercises measurements in animal species differ moderately from human researches.  
Generally studies were executed in laboratory mice’s or rats by taking biopsys from the test 
animals. Studies combined mainly different exercise protocols (treadmill, running wheel etc.) 
but almost without exception drugs were also used to simulate different effects of 
endocannabinoids. Efficiency of the exercise were not so specifically and entirely sdescribed 
as in human researches. More important was to concentrate on the effects of endocannabinoid 
system during or after the exercise by altering the endocannabinoid system by drugs or 
mutation and by compering these results to baseline. In order to do this different types of 
animal lines were used: 
 
- Wild type mice (WT) standard mice without any particular variations by using drugs or 
breeding or without special wheel running voluntarity. 
 
- High runner mice (HR) Mice (Mus domesticus) have been selectively bred on the basis of 
their higher voluntary wheel running performance (High Runner lines, HR), compared to 
unselected Control lines. Concomitant with increases in voluntary wheel running, HR mice 
have also undergone a shift toward increased levels of spontaneous physical activity in cages 
when wheels are absent (Malisch et al. 2009). Likewise, when running wheels were locked, 
HR mice spent more time climbing in the locked wheels, apparently trying to run (Koteja et al. 
1999). In addition to changes in locomotor behaviour, the selective breeding regimen has led 
to changes in capacities for aerobic exercise (Kolb et al. 2010), and in various lower-level 
morphological and physiological traits that may affect endurance capacity (Garland 2003). For 
example, HR mice exhibit reduced total body mass (Swallow et al. 1999), reduced body fat 
(Vaanholt et al. 2008), more symmetrical hind limb bones (Garland and Freeman 2005), 
higher circulating corticosterone (Malisch et al. 2008) and adiponectin levels (Vaanholt et al. 
2007), as well as increased plasticity of some traits in response to wheel access (Gomes et al. 
 2009). 
 
- Knock out mice (KO) the genetic knockout of mouse CB1 receptors allows investigating the 
consequences of the absence of CB1 receptors without the possible confounding variables 
linked to pharmacological approaches (Doubrec 2010).  Knock out effect is possible to create 
by genetic alteration of the mouse or by systemic (s.c.) and central (i.t., i.c.v.) pre-treatment 
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with CB1 and CB2 cannabinoid receptor antagonists. (agonist is chemical that binds to a 
receptor and activates the receptor to produce a biological response). Antagonist is receptor 
ligand or drug that blocks or dampers agonist mediated responses. 
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3 ENDOCANNABINOID SYSTEM 
 
Endocannabinoids are evolutionary well-preserved neurobiological systems that control key 
elements in the organ homeostasis (Hill and McEwen 2010) and wide range of biological 
processes (e.g. food intake, energy balance, nociception, intestinal motility and immune 
responses) (Basu et al. 2014). This system was in contrast to its long phylogenetic existence 
discovered late in the 1980s consists of the following elements: cannabinoid receptors, 
endogenous ligands, specific proteins involved in the endocannabinoid biosynthesis and 
degradation enzymes like fatty acid amide hydrolase (FAAH) (De Petrocellis et al. 2009). 
Endocannabinoids are natural and endogenous compounds found in mammalian tissues and 
cells (Basu et al. 2014). Endocannabinoids inhibit neuronal activity via cannabinoid receptors 
(Felder et al 1993) and are synthesized ‘‘on demand’’ and released from cells immediately 
after their synthesis and can hereby quickly react to different stressful conditions (Feuerecker 
2011). 
By the mid-1990's, the first two endocannabinoids, N-arachidonoylethanolamine 
(“anandamide”) (AEA) and 2-ara-chidonoylglycerol (2-AG), were identified and characterized 
as derivatives of the polyunsaturated fatty acid, arachidonic acid (AA) (Venuri et al. 2008) 
The third ether-type endocannabinoid, 2-arachidonylglycerol ether (noladin ether), was 
isolated from the CNS (central nervous system) and shown to display pharmacological 
properties similar to AEA. The fourth type of endocannabinoid, virodhamine, in contrast to the 
previously described endocannabinoids, is a partial agonist with in vivo antagonist activity at 
the CB1 receptor. The fifth type of endocannabinoid, N-arachidonyldopamine (NADA), not 
only binds to CB1 receptor but also stimulates vanilloid receptors (VR1). Consequently five 
types of endocannabinoid have been recognised so far  (Figure 1). Previously, the existence of 
AEA analogs in chocolate had been demonstrated. Endocannabinoids are present in peripheral 
and brain tissues and have recently been found in breast milk. It is thought that chocolate and 
cocoa contain N-acylethanolamines (NAEs) and oleamide, but no or very little AEA and no 2-
AG.  Since the information on noladin ether, virodhamine, and N-arachidonyl- dopamine is 
limited, the detailed discussion is restricted to AEA and 2-AG (Basavarajappa 2007).  
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Fig. 1 Chemical structures of endocannabinoids (modified Di Marzo et al. 2004) 
 
 
 
 
 
 
 
 
 
3.1 Endocannabinoid receptors 
Evidence for the existence of the marijuana receptor has been accumulating since the 1980s. It 
has now been shown that cannabinoids have two specific G-protein-coupled cannabinoid 
receptor subtypes, which have been cloned. These are named CB1 and CB2. Evidence for a 
third type of G-protein-coupled cannabinoid receptor (“CB3” or “Anandamide receptor”) in 
brain and in endothelial tissues is mounting. However, the cloning, expression and 
characterization of CB3 is yet to come. (Basavarajappa 2007) 
 
The CB1 receptor is mainly expressed in the brain and spinal cord and thus is often referred to 
as the “brain cannabinoid receptor” (Basavarajappa 2007) still many of the central effects 
and peripheral effects of cannabinoids depend on CB1-receptor activation (Guzman 2003).  
CB1 receptors are among the most abundant G-protein- coupled receptors in the brain 
(McPartland 2014), particularly in discrete areas that are involved in the control of motor 
activity (basal ganglia and cerebellum), memory and cognition (cortex and hippocampus), 
emotion (amygdala), sensory perception (thalamus), and autonomic and endocrine functions 
(hypothalamus, pons and medulla) (Guzman 2003). In the brain highest densities of CB1-
receptors are found in association with limbic cortices, with much lower levels within the 
primary sensory and motor regions, suggesting an important role in motivational (limbic) and 
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cognitive (associative) information processing. In addition, CB1 receptors presynaptic location 
on GABAergic interneurons and glutamatergic neurons and their densities being similar to the 
levels of alfa-aminobutyric acid (GABA)- and glutamate-gated ion channels suggest the 
proposed role of endocannabinoid compounds in modulating neurotransmission 
(Basavarajappa 2007).  
 
CB1 receptor is also expressed in peripheral nerve terminals, various extraneural sites 
(Guzman 2003) and in non-neuronal cells, such as (MacPartland 2014) endocrine -related 
bodies in the thyroid gland, the adrenal medulla, reproductive organs, internal organs are the 
liver (liver cells, in addition to Kupffer cells of the liver, or macrophages) in the lungs and 
kidneys. Other major cell types include endothelial cells (e.g., blood vessel walls), glial cells, 
astrocytes (Galiegue et al. 1995), adipocytes and hepatocytes, and musculoskeletal tissues 
(McPartland 2014). 
 
From the genetic aspect encoding the CB1 receptor gene CNR1, which is located on 
chromosome 6 in humans. The gene has a single exon that encodes a protein of 473 amino 
acids in size. The corresponding receptor is found in vertebrates animals. The gene is highly 
conserved, sequence identity to the human and other mammals is more than 90 percent. 
Alternate form of the receptor is known, a base 167 which is spliced out. The short form 
expressed less, less than 20 percent of the observed A – RNA (Ribonucleic acid) and its 
translation is likely to be not effective (Pertwee et al. 2009). 
 
The CB2 receptor is sometimes referred to as the “peripheral cannabinoid receptor” because 
it was thought that CB2 receptors were predominantly present in immune cells in the 
periphery and absent from the brain (Basavarajappa 2007). Recent studies suggested that CB2 
cannabinoid receptors are functionally expressed in neurons in the brain, in nonparenchymal 
cells of the cirrhotic liver, in the endocrine pancreas, and in bone (Pacher 2006). CB2 are 
mainly found in immune defense cells, such as macrophages, B lymphocytes, blood stem cells 
and organs of the immune system, e.g. spleen, tonsils, and thymus. (Galiegue et al. 1995). 
Other cell types in the CB2 is expressed on keratinocytes (skin cells produce keratin), mouse 
pre-implantation embryos and peripheral nerve endings. CB2 in the brain occurs in microglia, 
or glial cells (Cabral et al. 2008). In the gastrointestinal tract CB2 receptors regulate intestinal 
inflammatory reactions (Wright et al. 2008). CB2 receptor mRNA has been found in the 
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spleen, tonsils, and thymus, which are the major tissues of immune cell production and 
regulation. CB2 agonists generally suppress the functions of these cells, but both CB1 and 
CB2 receptors could contribute to these effects (Basavarajappa 2007)  
The CB2 receptor CNR2 encodes a gene that in humans is located on chromosome 1. The 
protein is 360 amino acids and has a shorter at the N -terminal part of the CB1 respectively. 
CB1 and CB2 sequence identity is 44 %, the membrane permeable components of 68%. The 
receptor is found only in mammals, so it is probably evolutionarily young. Interspecies 
sequence identity of more than 80 per cent, but the variation is greater than the CB1 
respectively (Galiegue ym.1995). 
3.2 Endocannabinoid synthesis and metabolism 
The precursor for the synthesis anadamide (AEA) is the membrane phospholipid and N-
arachidonylphosphatidylethanolamine (NAPE), which are common elements of structure of 
biological membranes. N-acyltransferase (NAT) catalyzes the conversion of 
phosphatidylethanolamine to N-arachidonylphosphatidylethanolamine (NAPE). Phospholipase 
D cleaves the NAPE 's, which consists of anandamide. Synthesis of anandamide there are 
other potential routes, for example phospho-AEA intermediate. Neurotransmitters released 
from the postsynaptic neuron putative transporter protein through the synaptic cleft. 
Anandamide into the synaptic cleft back into the postsynaptic neuron driver putative protein. 
Fatty acid amide hydrolase (FAAH) breaks down anandamide into arachidonic acid and 
ethanolamine (Pacher et al. 2006, Basavarajappa 2007), 2 - arachidonyl glycerol is synthesized 
in the postsynaptic neuron. Phospholipase D catalyzes the conversion acyl arkidonyl glycerol 
which diacylglycerol lipase edit into 2 - AG. 2- AG is taken into the presynaptic cell, where 
Monoacylglycerol lipase (Magl) break it ethanolamineand arachidonic acid ( Figure 2) . ( 
Pacher et al. 2006 ) . 
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Fig. 2. Endocannabinoid system in pre- and postsynaptic neurons (moderate Pacher 2006)  
 
 
 
The presynaptic terminal is located in the top, whereas the postsynaptic neuron is located in 
the bottom. Endocannabinoid (EMT), membrane transporter (MAGL), anandamide (AEA), 2- 
arachidonoylglycerol (2-AG), phospholipase D (PLD), phospholipase C (PLC), N-arachidonyl 
phosphatidylethanolamine (NAPE), N-acyltransferase (NAT), acylarachidonylglycerol 
(DAGL), fatty acid amide hydrolase (FAAH) (Pacher 2006). 
 
3.3 Endocannabinoid signalling 
Endocannabinoids inhibit neuronal activity via cannabinoid receptors (Felder et al 1993, 
Griffin et al 2000). The presynaptic neuron cannabinoid receptor activates potassium channels 
and protein kinases which are associated with G-proteins, to reduce the cyclic AMP by 
inhibiting adenylate cyclase and blocks the release of neurotransmitters regulating calcium 
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channels (Figure 3). Thus the effects of the synaptic vesicle release are reduced (Kreitzer and 
Regehr 2002). Endocannabinoids can switch back to the postsynaptic cell plasma actively by 
membrane transporter or by passive diffusion. Inside the cell fatty acid amide hydrolase breaks 
anandamide into arachidonyl acid and ethanolamine, when this bioactive lipid ceases to have 
effect (Bisogno et al. 2002). 
 
Both CB1 and CB2 are coupled with Gi or Go proteins (Basavarajappa 2007). Binding of 
cannabinoid CB1 or CB2 receptor, the receptor activates association with a trimeric G protein. 
Gi / o protein alpha- subunits inhibit adenylyl cyclase activity. Adenylyl cyclase synthesizes 
the second messenger cAMP formation. cAMP binds to protein kinase A (PKA). By PKA 
phosphorylates other proteins , such as transcription factor CREB (cAMP responsive element). 
cAMP decreases the production of nerve cells which express the CB1 receptors and white 
cells that express CB2 receptors. When the cAMP and PKA inhibition of the function of 
signalling pathways, transcription of protein synthesis and cell activities and thus a change 
(Howlett et al. 2004). 
 
CB1 receptor associated G protein beta and gamma subunits form a complex. Complex 
activates the MAPK (mitogen activated protein kinase) signal paths. Activated kinases include 
the ERK, JNK , PKB / Akt and p38 (Basavarajappa 2007). Pathways control many cellular 
functions, including gene expression, mitosis, cell division and apoptosis (Savolainen et al. 
2004). Cannabinoid binding to and activation of G- protein, leading to changes in ion channel 
activity. Anandamide binding to CB1 receptor reduces the flow of calcium into the cell by 
preventing the voltage- L-N- P, and Q ion channel function (Basavarajappa 2007). L-type 
calcium channels present in skeletal muscle, N-type presynaptic neurons of P-type cerebral 
cortex and Purkinje cells of the Q- type cerebellum (Pertwee et al. 2009). CB1 activation 
increases the flow of potassium inside the cell by activating potassium channels (G protein -
coupled inwardly rectifying potassium channel, Girk) operations (Savolainen et al. 2004). In 
marked contrast to many neurotransmitters that are stored within intracellular vesicles 
awaiting mobilization in bioactive form, endocannabinoids are synthesized “on demand” in 
response to stimulus-induced intracellular calcium elevation (Venuri et al. 2008). 
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Fig. 3. Cannabinoids effect on cellular signal transduction (modified Savolainen et al. 2004)  
 
 
 
Endocannabinoids affect cell growth, function, and apoptosis in several different ways. CB1 
receptor influences in protein kinases (PKA, PKB, ERK, JNK, p38), cyclic AMP (cAMP) and 
ion channels (sodium, potassium and calcium channels) by using G-protein (Gi / o). In 
addition CB1 receptor influences also in lipid mediators (ceramide). The blue arrows show the 
activation, red lines implicates inhibition and black arrows depicts metabolic pathways. SM = 
sphingomyelin SMase = sphingomyelinase, FAN = G protein independent of an adapter 
protein, Girk = pottasium  (G protein-activated inwardly rectifying K + channel) (Savolainen 
et al. 2004). 
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4 RUNNERS HIGH 
 
An exercise induced altered state of consciousness has long been appreciated by endurance 
athletes. The effect has been well documented in the popular literature and subjected to 
scientific investigation. In the late 1960s, the psychological changes associated with prolonged 
physical activity were often described as a ‘‘second wind.’’ A more contemporary label often 
applied to these exercise induced changes is the ‘‘runner’s high.’’ (Dietrich 2004). Endurance 
training has been reported to induce a variety of psychophysical effects, including stress 
reduction, anxiolysis, mood elevation, and reduced pain perception (Boecker 2008). Moreover 
goal-oriented behaviours that impose risks or high energy costs are often motivated by 
neurobiological rewards, which are thought to condition fitness-enhancing activities. Humans 
frequently report such neurobiological rewards during and after distance running these 
rewards like described above include both central effects (improved affect, sense of wellbeing, 
anxiety reduction, post-exercise calm) and peripheral effects (reduced pain sensation). Central 
and peripheral rewards likely play a major role in humans’ motivation to run, and increase 
their ability to sustain high aerobic intensities over long distances (Raichlen 2011). 
Consequently the runner’s high has been described subjectively as pure happiness, elation, a 
feeling of unity with one’s self and/or nature, endless peacefulness, inner harmony, boundless 
energy, and a reduction in pain sensation. These subjective descriptions are similar to the 
claims of distorted perception, atypical thought patterns, diminished awareness of one’s 
surroundings, and intensified introspective understanding of one’s sense of identity and 
emotional status made by people who describe drug or trance states (Dietrich 2004). 
Obviously, as is the case with all phenomena related to consciousness and its alterations, the 
runner’s high is a individual experience, and the evidence for its existence rests predominantly 
on verbal report. The runner’s high is not experienced by all runners, and this experience does 
not occur consistently in runners who have experienced it previously. At first glance, it 
appears that the runner’s high phenomenon is, at present, not a scientific problem because it is 
built on circumstantial evidence and lacks a plausible mechanistic explanation (Dietrich 2004). 
However recent studies show that in a matter of fact exercise activates the endocannabioid 
system (eCBs) in humans and other mammals generating these rewards during and after 
exercise (Raichlen 2011). In addition eCBs are partly responsible for the reported 
improvements in mood and affect following aerobic exercise in humans (Raichlen 2012). 
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The cannabinoids produce psychological states that closely parallel several experiences 
described as being related to the runner’s high. Compared with the opioid analgesics, the 
analgesia produced by the endocannabinoid system is more consistent with exercise-induced 
analgesia. Activation of the endocannabinoid system also produces sedation, anxiolysis, a 
sense of wellbeing, reduced attentional capacity, impaired working memory ability, and 
difficulty in time estimation. This behavioural profile is similar to the psychological 
experiences reported by long distance runners (Dietrich 2004).  
Endocannabinoids were originally identified as the receptors activated by D9-
tetrahydrocannabinol (THC; the principal psycho- active ingredient in marijuana). CB1 
receptors are found in numerous brain areas, but are particularly dense in regions associated 
with emotion, cognition, motor behaviour, and reward. The two most studied eCBs, AEA and 
2-AG, are released by neurons in an activity-dependent manner to modulate synaptic activity 
and plasticity. Through this activity, eCBs may contribute to exercise-related changes in 
psychological state (Raichlen 2012) 
Several lines of evidence suggest that the eCB system is involved in neurobiological rewards 
associated with aerobic exercise and runners high phenomenon. First, circulating levels of 
eCBs increase following treadmill running and cycling in humans. Since eCBs are highly 
lipophilic, circulating eCBs can readily pass through the blood–brain barrier, leading to central 
effects. Note that movement of eCBs across biological membranes is facilitated by recently 
characterized transporter proteins and might be dynamically modified by physiological 
processes. Second, studies of animal models suggest a role for eCBs in the motivation to 
exercise. For example, in cannabinoid (CB) receptor knockout mice, voluntary wheel-running 
is significantly reduced compared with control groups. This reduction suggests that the eCB 
system is involved in the motivation for voluntary exercise in these animal models. 
Additionally, in female mice that have undergone artificial selection for high amounts of 
voluntary wheel-running, administration of rimonabant (SR141716; a CB1 receptor 
antagonist) or WIN 55,212-2 (a CB1 receptor agonist) significantly reduced wheel-running 
compared with mice that have not undergone the selection experiment. The fact that selected 
mice experience a differential response to eCB signalling suggests that evolution can act on 
the eCB system to help motivate exercise. Finally in Long-Evans rats, rimonabant injections 
suppressed operant responding to attain access to a running wheel, again supporting a role for 
eCB signalling in the reinforcing properties of exercise (Raichlen 2012). 
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5 METHODS 
 
Aim of this study is to compile a systematic literature review of endocannabinoids and 
exercise from the viewpoint of recent human and animal researches in order to assess how 
exercise with different variables effects or activates endocannabinoid system. 
 
Research questions: 
- How exercise activates human endocannabinoid system? 
- How exercise affects endocannabinoid system in test animal models? 
5.1 Database search 
PubMed, Ebscohos, Scopus and Psycinfo databases were searched for available literature to 
May 2014. Same search terms “exercise”, “endocannabinoid”, “endocannabinoids” and 
“sport” were used in all four databases. The yield of publications in the search is depicted in  
TABLE 4. 
The articles were firstly evaluated by the abstract. Potential articles were included to full text 
evaluation with a mutual undestanding of two independent authors. Discrepancies were 
resolved by discussions. Articles which focused on endocannabinoids and exercise but also 
had own described exercise protocol (animal or human) were chosen. The reference of 
selected articles and the related citations in databases were searched for other potentially 
relevant articles. Systematic literature reviews themselves or articles which did not have 
accurate exercise protocols were excluded.  Finally articles which did not have free 
accessibility by using UEF admin were also excluded.  
5.2 Assessment of literature 
 
Studies were evaluated using the following criteria: -­‐ study design – exercise protocol -­‐ study duration -­‐ study population – sample size, age, representativeness -­‐ outcome measures -­‐ limitations of the studies 
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TABLE 4. Flow chart of the systematic literature search. Number refer to amount of 
publications.  KEY	  WORDS	   exercise+endocan.	   sport+endocan.	  DATABASE	   	   	  Pubmed	   74	   15	  Title	  of	  abstract	  evaluation	   28	   9	  Full	  text	  evaluation	   23	   8	  Approved	   19	   6	  Ebscohost	   35	   10	  Title	  of	  abstract	  evaluation	   18	   6	  Full	  text	  evaluation	   18	   4	  Approved	   13	   3	  Psycinfo	   17	   22	  Title	  of	  abstrach	  evaluation	   11	   1	  Full	  text	  evaluation	   10	   1	  Approved	   10	   1	  Scopus	   102	   3	  Title	  of	  abstract	  evaluation	   21	   1	  Full	  text	  evaluation	   17	   1	  Approved	   15	   1	  TOTAL	   16	   	  Articles	  included	  in	  the	  review	   16	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6 RESULTS 
 
A total of 16 articles were examined. Six articles included in this systematic review had been 
included in the previous systematic review on the therapeutic implications the 
endocannabinoid system for the treatment of obesity (Heyman 2012). Articles of this study 
were categorized into human research (6) and animal research (10). One study was a 
combination from the both categories (Raichlen 2012). The studies were published between 
2003 (Sparling) and 2014 (Ferreira-Viera). All the results are from both categories displayed 
in TABLE 5 and TABLE 6 which are attached at end of this review.  
6.1 Human researches  
In human researches (TABLE 5) the subject sample size varied between 10 (Raichlen 2012) 
and 30 (You et al. 2011) participants. The mean age in human research study population 
ranged from 23,3 (Heyman et al. 2012) to 34,3 (You et al. 2011). In two studies subjects 
weight was notified in body mass index (BMI)  and in other four with body mass (kg). Mean 
BMI varied between 21,8 (Feurerrecker 2012)  and 34,3 (You et al. 2011) and mean body 
mass between 67,35 kg (Raichlen 2013) and 77,4 kg (Heyman 2012). In five studies subjects 
were either well trained (Heyman 2012), trained (Feurerrecker 2012, Sparling 2003)  or fit 
(Raichlen 2012, Raichlen 2013) cyclists, mountaineers or  regular runners. In only one study 
subjects were overweight or obese and sedentary (You 2011).  
In five studies, study designs were linked to endocannabinoid system and exercise. In four 
cases, studies focused directly on the effects of physical exercise in endocannabinoid system 
(Feurerrecker 2012, Heyman 2012, Raichlen 2013 and Sparling 2003). However approaches 
were diverse in these studies such as for the effects of exercise in different altitudes 
(Feurerrecker 2012) during varying exercise intensities (Raichlen 2013), or only moderate 
intensity exercise (Sparling 2003)  on endocannabinoid system were investigated.  In addition 
link between serum BDNF were also studied (Heyman 2012). Two studies had a dissimilar 
approach. One study focused on neurobiological reward linked to high intensity exercise 
between cursorial and non-cursorial mammals (Raichlen 2012). Finally  one study  examined 
whether  hypo caloric diet and aerobic exercise influence subcutaneous adipose tissue 
cannabinoid type 1 receptor (CB1) and fatty acid amide hydrolase (FAAH) gene expression in 
obese women (You 2011). 
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TABLE 5. Human researches 
 
Study Study desing Subjects Protocol Intensity Results 
Feuerecker 
et al. 2012 
Study investigated in 
a crossover design 
and under field 
conditions at 
different altitudes the 
effects of physical 
exercise on the 
endocannabinoid 
system 
. 
 
12  trained 
male 
mountaineers  
Average age 
27.6 
BMI 21.8-
+2.7 (SD) 
Protocol A: 
physical exercise 
by hiking at 
lower altitude, 
physical exercise 
by hiking for a 
total time of 4–
4.5 h below an 
altitude of 2,100 
m. 
Protocol B: 
physical exercise 
by active ascent 
to high altitude, 
combination of 
strenuous 
physical exercise 
and high 
altitude. The 
difference in 
altitude was 
1,780 m up to 
3,196 m and the 
total hiking time 
was 3.5 - 5.5 h 
Protocol C: 
passive ascent to 
high altitude, 
passive ascent to 
high altitude 
3,196 m by 
helicopter 
accommodation 
and a flight back 
to the base camp 
24 h after the 
ascent 
- AEA levels measured during the 
physical exercise below 2,100 m were 
significantly increased directly and 
after the exercise (p < 0,05)  and 
additionally, an increase of the 2-AG 
concentrations could be quantified  
Hiking to 3,196 m caused also a 
significant, triple fold increase of 
AEA with no remarkable changes in 
2-AG levels. Passive ascent by 
helicopter had no effect on the 
endocannabinoid blood 
concentrations of AEA and 2-AG 
An increase of the catecholamine 
epinephrine was measured after 
physical activity to high altitude and 
showed a positive and significant 
correlation with anandamide: AEA. 
No significant correlations were 
observed for other time points or in 
study protocols A and C. 
ECS is activated upon strenuous 
exercise whereas the combination 
with hypoxic stress further increases 
its activity. The reduced partial 
pressure of oxygen at high altitude 
alone did not affect this system. 
Physical exercise activates the 
endocannabinoid system, whereas the 
combination with high altitude 
enhances this activation. 
Heyman et 
al. 2012 
Study investigated 
the effects of an 
intense exercise on 
plasma levels of 
endocannabinoids 
(anandamide, AEA 
and 2-
arachidonoylglycerol, 
2-AG) and their 
possible link with 
serum BDNF. 
11 well-
trained male 
cyclists. Age 
23.3-
+5.1(SD) 
years, body 
mass 77.4-
+8.3 (SD) kg 
 
Long duration 
exercise 
protocol: 
Pedaling 
ergometric 
bicycle 60 min 
moderate 
intensity 
Time trial 
protocol 
followed 
immediately 
after moderate 
exercise: 
Subjects were 
55% of 
Wmax 
 
 
 
75% of 
Wmax 
AEA levels increased during exercise 
and the 15 min recovery (P < 0.001),,, 
whereas 2-AG concentrations 
remained stable.  
BDNF levels increased significantly 
during exercise and then decreased 
during the 15 min of recovery.  
AEA and BDNF concentrations were 
positively correlated at the end of 
exercise and after the 15 min 
recovery ( P < 0.05) 
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requested to 
complete a 
predetermined 
amount of work 
equal to 30 min 
at 75% of Wmax 
as quickly as 
possible 
Raichlen 
et al. 2012  
 
Study Investigates if 
neurobiological 
rewards are linked to 
high-intensity 
exercise in cursorial 
mammals and if 
neurobiological 
rewards may explain 
variation in habitual 
locomotor activity 
and performance 
across mammals 
10 
recreationally 
fit human 
(mixed-breed 
dogs (N=8) 
and ferrets 
(N=8) were 
shown in 
animal 
research 
table) 
Treadmill 
running 30 min 
 
 
 
 
 
Treadmill 
walking 30 min 
averaged 
72.5±2.54% 
of 
maximum 
heart rate 
(age based 
equation)  
walking 
speed 
44.6±1.25% 
of 
maximum 
heart rate 
(age based 
equation) 
 
Both humans and dogs showed a 
significant increase in plasma levels 
of AEA following a 30 min treadmill 
run (P=0,03).. Neither showed 
increased AEA levels following a 
lower intensity 30 min walk. Ferrest 
showed no change in neither protocol.  
Humans showed no significant 
change in levels of 2-AG following 
exercise trial.  
Raichlen 
et al. 2013 
Study examines 
changes in 
circulating eCBs 
following exercise at 
a wide variety of 
intensities under 
standardized 
conditions. 
circulating eCBs is 
examined before and 
after exercise at four 
different intensities, 
with each 
measurement 
occurring on a 
separate day. 
 10 self 
reported 
healthy, fit 
regular 
runners. Age 
31.91-+12,08 
(SD) Body 
mass 67,35-
+9,06 (SD) 
kg 
(6 males 
4 females) 
 
Walk or run on 
the treadmill at 
one of four 
intensities for 30 
min. 
 
Age-
adjusted 
maximum 
heart rate 
(AAMHR) 
I Intensity 1 
< 50%  
II Intensity 
2 -70%  
III Intensity 
3 -80%  
IV Intensity 
4 -90% 
Exercise intensities II and III led to a 
significant increase in post-exercise  
AEA levels.  
Exercise intensity II  had a 
significantly greater difference 
between post- and pre-exercise levels 
of AEA compared with intensities I 
(P=0.005) and IV (P=0,008) 
Exercise-induced AEA release in the 
bloodstream is dependent on exercise 
intensity. Only moderate exercise 
intensities (*70–85 % of AAMHR) 
lead to significant changes in 
circulating levels of AEA. Circulating 
levels of 2-AG are not influenced by 
exercise at any intensity. 
 
 
 
Sparling et 
al. 2003 
Study investigated 
the effects of 
moderate intensity 
exercise on the 
endocannabinoids 
plasma levels 
24 Trained 
males  
Age 23.779.4 
years, Body 
mass 
74.577.9 kg 
In a temperature 
controlled room 
(mean 
temperature 22 
C), exercise 
began with a 
5min warm-up 
which followed: 
Running 45 
Heart rate 
in the range 
of 70–80% 
of 
maximum 
heart rate. 
 
Plasma anandamide levels were 
significantly elevated in runners p < 
0.01) and cyclists (p < 0.05, but not 
sedentary controls. Exercise activates 
the endocannabinoid system.  
 
  25 
min(n=8), 
cycling 45 
min(n=8) 
sedentary 
controls 45 min 
(n=12) 
 
You et al. 
2011 
Study determines 
whether gene 
expression levels of 
cannabinoid type 1 
receptor (CB1) and 
fatty acid amide 
hydrolase (FAAH) 
are different in 
subcutaneous 
abdominal and 
gluteal adipose 
tissue, and whether 
hypo caloric diet and 
aerobic exercise 
influence 
subcutaneous adipose 
tissue CB1 and 
FAAH gene 
expression in obese 
women. 
30 
overweight 
or obese, 
middle-aged 
women  
(BMI = 34.3 
± 0.8 kg/m2, 
age = 59 ± 1 
years) 
 
20-week weight 
loss 
interventions: 
caloric 
restriction only 
(CR, N = 9) 
 
 
caloric 
restriction plus 
moderate-
intensity aerobic 
exercise CRM (, 
N = 13) 
 
caloric 
restriction plus 
vigorous-
intensity aerobic 
exercise CRV (, 
N = 8) 
 
Both 
groups 
walked on a 
treadmill 
three 
days/week 
treadmill 
walking 
from 15-20 
min at 45-
50% of 
HRR 
during the 
first week  
Which 
followed  
55 min at 
45-50% 
HRR for 
CRM group  
and 30 min 
at 70-75% 
HRR for 
CRV group 
by the 
second 
month. 
 
Adipose tissue CB1 and FAAH gene 
expression levels before and after the 
interventions in all 3 groups: there 
were no group differences in adipose 
tissue CB1 and FAAH mRNA levels. 
Compared to pre-intervention,  
CR alone did not change abdominal, 
but decreased gluteal CB1 and FAAH 
gene expression.  
CRM or CRV alone did not change 
abdominal and gluteal adipose tissue 
CB1 and FAAH gene expression. 
Combined CRM and CRV groups 
decreased abdominal adipose tissue 
FAAH gene expression.  
The changes in gluteal CB1 and 
abdominal FAAH gene expression 
levels in the CR alone and the 
CRM+CRV group were different or 
tended to be different. 
 
 
 
 
 
 
 
All of the studies have their own study protocol which was adjusted for a particular research 
object. However there were also similarities between studies. In four studies protocol included 
treadmill running or walking (Sparling 2003, Raichlen 2012, Raichlen 2013, You 2011). 
Running or walking time per exercise period varied between 30 min and 60 min and mean 
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heart rate indicating intensity varied between 44,6 and 92,1 beat/ min in age-adjusted 
maximum heart rate (AAMHR) scale. The remaining two studies had different exercise 
protocols. In one study physical exercise was conducted by hiking in high altitude between 
1780m-3196m in which hiking time varied between 3,5h-5,5h (Feurerrecker 2012). In addition 
two studies included cycling in exercise protocol (Heyman 2012, Sparling 2003). Cycling time 
varied between 30min-60 min. First study was a combination of cycling and running in which 
intensity of cycling was reported in VO2max and in this study mean intensities varied between 
55%-75% VO2max (Sparling 2003). In second cycling study intensity varied between heart rate 
in the range of 70–80% of maximum heart rate (Heyman 2012).  
In five human studies results indicated that exercise increased the levels of endocannabinoid 
anandamide (AEA) during (Heyman et al. 2012, Feurerrecker 2012, Sparling 2003, Raichlen 
2012, Raichlen 2013) and after the exercise (Feurerrecker 2012) regardless of exercise 
protocol. It was also noticed exercise in all intensities  increased the levels of AEA but 
moderate exercise intensities (*70–85 % of AAMHR) lead to most significant changes in 
circulating levels of AEA (Raichlen 2013) whereas, sedentary controls (Sparling 2003), 
passive ascent from high altitude (Feurerrecker 2012) or a lower intensity 30 min walk 
(Raichlen 2012) did not elevated plasma anandamide levels.   
Moreover, in four studies the levels of endocannabinoid 2-AG showed no remarkable changes 
during or following exercise (Heyman et al. 2012, Feurerrecker 2012, Raichlen 2012, Raichlen 
2013) in any intensity level (Raichlen 2013). However in pioneer study (Sparling 2003) 
analysis of plasma 2-AG showed a similar trend with increases for runners and cyclists as 
AEA while an ANOVA (analysis of variance) revealed no significant results. It has been 
stated that difference may be attributable to functional divergences between AEA and 2-AG, 
which are synthesized via different biochemical pathways and may be produced under 
different conditions. In addition in one study increase of 2-AG concentration levels during the 
physical exercise below 2,100 m could be quantified (Feurerrecker 2012) however same study 
stated that hiking to 3,196 m caused no remarkable changes in 2-AG levels. Consequently all 
findings implies that generally exercise does not have significant effect on 2-AG.  
Additional findigs in humans studies suggests that physical exercise activates the 
endocannabinoid system, whereas the combination with high altitude enhances this activation 
(Feurerrecker 2012). Furthermore BDNF (Brain-derived neurotrophic factor) levels increased 
significantly during exercise and then decreased during the 15 min of recovery (P < 0.01). 
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AEA and BDNF concentrations were positively correlated at the end of exercise and after the 
15 min recovery (P < 0.05) (Heyman 2012). In addition both humans and dogs showed a 
significant increase in plasma levels of AEA following a 30 min treadmill run (P=0,03) while 
as Ferrest showed no change in neither protocol (Raichlen 2012). Finally, exercise-induced 
AEA release in the bloodstream is dependent on the exercise intensity. Moderate exercise 
intensities (*70–85 % of AAMHR) lead to the most significant changes in circulating levels of 
AEA (Raichlen 2013).  
One study (You 2011) revealed rather dissimilar results due to different research approach and 
objects. While other studies concentrated on the connection between exercise and AEA, this 
study determined whether gene expression levels of cannabinoid type 1 receptor (CB1) and 
fatty acid amide hydrolase (FAAH) are different in subcutaneous abdominal and gluteal 
adipose tissue, and whether hypo-caloric diet and aerobic exercise influence subcutaneous 
adipose tissue CB1 and FAAH gene expression. Results showed that caloric restriction diet 
(CR), Caloric restriction diet + moderate  intensity exercise (CRM) or Caloric restriction diet 
+ vigorous intensity exercise (CRV) alone did not change abdominal and gluteal adipose 
tissue CB1 and FAAH gene expression. Combined CRM and CRV decreased abdominal 
adipose tissue FAAH gene expression. The changes in gluteal CB1 and abdominal FAAH 
gene expression levels in the CR alone and the CRM+CRV group were different or tended to 
be different. 
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6.2 Animal  researches 
In animal researches (TABLE 6) sample size varied between 16 (Gomez da Silva 2010) and 
96 (Keeney 2012) (sample size were not reported in all studies)  
TABLE 6. Animal researches 
Study Study design Subjects Protocol  Results 
Doubreuc 
et al. 2013 
Analyzed the 
respective impacts of 
constitutive/conditional 
CB1 receptor 
mutations and of CB1 
receptor blockade on 
wheel-running 
performance. 
 
male  
wild-type and 
mutant mice: 
constitutive 
CB1 receptor 
mutant mice 
(CB–1
/–), 
conditional 
mutant mice 
lacking CB1 
receptors from 
principal 
neurons 
(CaMK-CB–
1
/–), brain 
GABAergic 
neurons 
(GABA-CB–
1
/–), cortical 
glutamatergic 
neurons (Glu-
CB–1
/–), 
serotonergic 
neurons 
(TPH2-CB–
1
/–), dopamine 
D1 receptor- 
expressing 
neurons (D1-
CB–1
/–), glial 
fibrillary 
acidic protein- 
expressing 
astrocytes 
(GFAP-CB–
1
/–) 
 
 
 
 
 
 
 
Wheel running+locomotor 
activity+drugs 
Wheel running: 3-hour daily 
running episodes 1-3 weeks. 
Locomotor activity 
Drugs: Rimonabant 3mg/kg 
(CB1 receptor antagonist) 
 
 
Mutant mice lacking CB1 receptors 
from the whole body displayed low 
running activity, compared with 
wild type mice, the amplitude of this 
difference increasing with the 
number of running sessions 
CB1 receptor antagonist rimonabant 
to wild type mice mimicked the 
negative impact of the CB1 receptor 
mutation 
rimonabant also decreased wheel 
running when acutely administered 
to mice that had reached their 
maximal daily performance. 
Conversely, rimonabant 
administration to mice housed in 
cages equipped with activity 
detectors did not affect locomotor 
activity 
Conditional deletion of CB1 
receptors from brain GABA 
neurons, but not from several other 
neuronal populations or from 
astrocytes, decreased wheel-running 
performance in mice. The inhibitory 
consequences of either the systemic 
or the intra-VTA administration of 
CB1 receptor antagonists on running 
behaviour were abolished in GABA-
CB–1
/– mice. The absence of CB1 
receptors from GABAergic neurons 
led to a depression of VTA DA 
neuronal activity after 
acute/repeated wheel running. 
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De Chiara 
et al. 2010 
Assess cannabinoid- 
mediated transmission 
in the striatum after 
running wheel and 
sucrose consumption. 
investigated whether 
running wheel or 
sucrose consumption 
altered the sensitivity 
of striatal synapses to 
the activation of 
cannabinoid CB1 
receptors. 
 
Male mice (6 
weeks old) 
 
Wheel 
running+succarose+Drugs. 
Control group 
Succarose group: Succarose 
preference: drinking fluid 
containing sucrose (3% in 
tap water) 1,3,7,15 days 
Running wheel group 1, 3, 
7, 15, 30 days 
Aggressor test: Exposed to a 
different aggressor 10 min 
daily/ 3 days: control group 
and rewarded mice: exposed 
running wheel (15 days) or 
sucrose (7 days) group 
Open-field test: compare 
motor responses in stressful 
environment: control and 
rewarded mice: wheel 
running (15 days), sucrose 
(7 days)  
Drug protocol: AM251 
(CB1 antagonist) 6 mg/kg 
daily in mice pre-exposed to 
running wheel (15 days) or 
to sucrose (7 days) during 
the 3-day stress procedure. 
Controls having injections 
of vehicle. 
Drugs used in slices for the 
electrophysiological 
experiments: AM251 CB1 
receptor antagonist, HU210 
CB1 receptor agonist 
 
We found that cannabinoid CB1 
receptor-mediated presynaptic 
control of striatal inhibitory 
postsynaptic currents was 
remarkably potentiated after these 
environmental manipulations. In 
contrast, the sensitivity of glutamate 
synapses to CB1 receptor 
stimulation was unaltered, as well as 
that of GABA synapses to the 
stimulation of presynaptic GABAB 
receptors. The sensitization of 
cannabinoid CB1 receptor-mediated 
responses was slowly reversible 
after the discontinuation of running  
wheel or sucrose consumption, and 
was also detectable following the 
mobilization of endocannabinoids 
by metabotropic glutamate  
receptor 5 stimulation. Finally, we 
found that the upregulation of 
cannabinoid transmission induced 
by wheel running or sucrose had a  
crucial role in the protective effects 
of these environmental 
manipulations against the motor and 
synaptic consequences of stress.  
 
Ferreira-
Viera et al.  
2014 
Investigated the 
hypothesis that the 
memory-enhancement 
promoted by physical 
exercise relies on 
facilitation of the 
endocannabinoid 
system. 
 
Male mice (7–
8 weeks of 
age) 
Two groups 
(sedentary or 
trained, n = 36 
per group) 
Subdivided 
into three 
subgroups 
accordingly to 
treatment 
(vehicle, 
AM251, or 
URB597, n = 
12/subgroup) 
Motorized 
treadmill+Drugs 
The exercise protocol 
consisted of 7 consecutive 
days of forced running 
11m/min, 1 session/day, for 
30 min. 
Sedentary mice were placed 
on treadmill for 5 min/day 
speed 5m/min 
CB1  receptor antagonist 
AM251 (1mg/kg) or 
URB597 Fatty Acid Amide 
Hydrolase inhibitor (0.5 
mg/kg) 30 min before each 
The exercise paradigm used was 
able to improve animals’ spatial 
memory. Treatment with URB597, 
either associated treatment with 
URB597, either associated or not 
with the training also improved 
spatial memory. The treatment with 
AM251 prevented memory 
improvement caused by exercise or 
treatment with URB597. The 
physical exercise was able to 
promote an increase in CB1 receptor 
expression in the hippocampus. 
Moreover, treatment with FAAH 
inhibitor, which was able to mimic 
the behavioural effects of exercise, 
promoted a similar effect in 
sedentary animals. Accordingly, the 
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 period of physical activity. 
 
 
effects of exercise were prevented in 
animals treated with the CB1 
antagonist 
The post-hoc analyses confirmed 
that the exercise induced an increase 
in BDNF expression in the 
hippocampus of animals. Similarly, 
treatment with URB597, which 
mimicked the promnesic effect of 
exercise, was able to induce an 
increase in BDNF expression in 
sedentary animals as well as trained 
animals (Fig. 4A,B). Accordingly, 
the exercise effect on BDNF 
expression, similarly the promnesic 
effect, was prevented in animals 
treated with the CB1 antagonist. 
Gomez da 
Silva et al.  
2010 
Investigated the 
cannabinoid receptor 
type 1 (CB1) 
expression in the brain 
of rats trained during 
the adolescent period. 
 
Rats aged 21 
postnatal days-
old 
16 Rats 
Divided into 
two groups: 
exercise group 
(n = 8), control 
group (n = 8) 
 
 
 
 
Wheel running 
Exercise group: 5 min 
warm-up. Running time and 
speed gradually  increased 
during the subsequent days, 
until reaching max during 
60 min 18m/min. 
Aerobic exercise program performed 
during adolescence significantly 
reduced the CB1 receptor expression 
in the striatum and hippocampal 
formation. 
 
Galdiano  
et al. 2014 
Investigated the role of 
the endocannabinoid 
system in the 
mechanisms involved 
in the exercise-induced 
antinociception 
 
 
Male Wistar 
rats  
 
Treadmill+Drugs(n = 6 per 
group): Control (Co): 
animals that did not perform 
exercise and received saline; 
Acute aerobic exercise 
(AE): rats that ran and 
received saline;  
AE+AM251: animals pre-
treated with CB1 
cannabinoid receptor 
antagonist and exercised;  
AE+AM630: animals pre-
treated with CB2 
cannabinoid receptor 
antagonist and exercised;  
AE+MAFP: animals 
pretreated with irreversible 
FAAH inhibitor and 
Study revealed increase and 
activation of CB1 receptors in the 
rat brain, and immunofluorescence 
analysis demonstrated an increase of 
activation and expression of CB1 
receptors in neurons of the 
periaqueductal gray matter (PAG) 
after exercise. Pretreatment (s.c., i.t. 
and i.c.v.) with endocannabinoid 
metabolizing enzyme inhibitors 
(MAFP and JZL184) and an 
anandamide reuptake inhibitor 
(VDM11) prolonged and intensified 
this antinociceptive effect. 
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exercised;  
AE+JZL184: animals pre-
treated with MGL inhibitor 
and exercised;  
AE+VDM11: animals pre-
treated with inhibitor of the 
anandamide membrane 
transporter and exercised 
Acute aerobic exercise (AE) 
was performed using a 
rodent treadmill. Animals 
ran 5m/min at an average 
time of 49.06 (+/-) 3 min, 
until fatigue. 
Study protocol also included 
assessment of mechanical 
nociceptive threshold, 
assessment of thermal 
nociceptive threshold 
Hill et al.  
2005 
Study aimed to assess 
whether enhanced 
activity at the 
cannabinoid CB1 
receptor elicits 
antidepressant-like 
effects. 
 
Rats (10 
weeks) 
 
Forced swim test, Drugs. 
Forced swim test: Duration 
of immobility during 5 min 
test session 
Drugs: AM404; 5 and 25 
Ag/kg doses of HU-210, a 
potent CB1 receptor agonist; 
1, 2.5 and 5 mg/kg of 
oleamide, which elicits 
cannabinoidergic actions; 1 
and 5 mg/kg doses of AM 
251, a selective CB1 
receptor antagonist, as well 
as 10 mg/kg desipramine (a 
positive antidepressant 
control) 
 
 
Administration of desipramine 
reduced immobility duration by 
about 50% and that all of AM404, 
oleamide and HU-210 
administration induced comparable 
decreases in immobility that were 
blocked by pretreatment with AM 
251. Administration of the 
antagonist AM 251 alone had no 
effect on immobility at either dose.  
 
Hill et al.  
2010 
Determine whether the 
endocannabinoid 
system is regulated by 
voluntary exercise and 
if these changes con- 
tribute to exercise-
induced enhancement 
of cell proliferation in 
hippocampal plasticity. 
 
Male rats (70 
days old) 
 
Wheel running + drugs 
Experiment 1, free 
access to running wheel 
for 8 days  
 
Experiment 2, free access to 
running wheel for 8 days + 
AM251 (1mg/kg) CB1 
receptor antagonist. 
In Experiment 1, running wheel 
increased the agonist binding site 
density of the cannabinoid CB1 
receptor; CB1 receptor- mediated 
GTPcS binding; and the tissue 
content of the endocannabinoid 
anandamide in the hippocampus but 
not in the prefrontal cortex. In 
Experiment 2, cell proliferation in 
the hippocampus was examined 
through immunohistochemical 
analysis of the cell cycle protein Ki-
67. Voluntary exercise increased 
proliferation of progenitor cells, as 
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evidenced by the increase in the 
number of Ki-67 positive cells in the 
granular cell layer of the dentate 
gyrus (DG) in the hippocampus. 
This effect was abrogated by 
concurrent treatment with AM251. 
 
 
 
Keeney et 
al. 2012 
Study voluntary wheel 
running activity after 
administration of CB1 
receptor agonist (WIN 
55,212-2) to HR and 
Control mice of both 
sexes. 
Male and 
female mice. 
High runner 
line  (high 
voluntary 
wheel running) 
+ 4 additional 
lines 
 
Wheel running+Drugs 
Voluntary wheel running for 
24 days. Then received, in 
random order, either an 
intra-peritoneal injection of 
vehicle or a low (0.5 
mg/kg), medium (1 mg/kg) 
or high dosage (3 mg/kg) (of 
CB1 receptor agonist  
55,212-2 (WIN) followed 12 
days observation period 
included 10-120 min daily 
running 
 
Injection decreased wheel 
revolutions in all mice, but male HR 
mice decreased their running to a 
greater degree relative to Controls in 
response to the high dose of WIN 
over the entire period analyzed, 
whereas HR females showed a 
differential response relative to 
controls only in the latter 70–120 
min post-injection.  
 
Endocannabinoid signalling have 
diverged in four lines of mice bred 
for high levels of voluntary exercise 
and male and female HR mice differ 
from one another in CB1 signalling 
as it relates to wheel running. 
 
Rasmussen 
et al.  2011 
Study represents an 
attempt to elucidate 
whether naloxone and 
rimonabant may also 
reduce rewarding 
properties of activity-
based reinforcement. 
Rats (4–6 
weeks old) 
 
10 female 
obese rats 
 
10 female lean 
rats 
 
Wheel Running+Drugs 
Experiment 1, rats pressed a 
locked door under a 
progressive ratio schedule of 
reinforcement that, when 
unlocked, provided access to 
a running wheel for 2-min 
intervals. Doses of naloxone 
were administered prior to 
experimental sessions. 
 
Experiment 2, 5 rats pressed 
a door to unlock a wheel for 
20 s of wheel activity. Doses 
of rimonabant (1–10 mg/kg) 
were administered before 
some experimental sessions. 
 
 
 
 
 
 
 
 
Drugs reduce the reinforcing 
properties of wheel running, but do 
so in different manners: naloxone 
may suppress wheel-based activity 
(consummatory behavior), but not 
seeking (appetitive behaviour), and 
rimonabant does the converse. 
Endocannabinoids reinforces 
properties of exercise, an 
implication that is important in 
terms of CB1 antagonists as a type 
of pharmacotherapy. 
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Smith et 
al.  2010 
first, the value of 
wheel running as a 
reinforcer using PR 
schedules of 
reinforcement was 
established and 
compared in lean and 
obese Zucker rats. 
Second, we examined 
the effects of 2-AG on 
the reinforcing 
properties of wheel 
running in the lean and 
obese Zucker rat 
Zucker rats 
(approximately 
4–6 weeks old) 
 
10 female 
obese  
10 female lean 
 
Wheel running+drugs 
Rats pressed a locked door 
under a progressive ratio 
schedule of reinforcement 
that, when unlocked, 
provided access to a running 
wheel for 2-min periods.  
 
After baseline breakpoints 
were established, doses of 2-
AG were administered 
before experimental sessions 
 
 
Obese rats exhibited lower 
breakpoints for wheel activity, lower 
response rates, and fewer 
revolutions compared with lean rats.  
 
2-AG decreased breakpoints, 
response rates, and revolutions for 
obese rats, and revolutions only for 
lean rats. 
 
animals. The mean age ranged from 21 days (Gomez da Silva 2010) to 3 month (Doubreuc 
2013). Laboratory animals were either rats  (Gomez da Silva  2010, Galdiano 2014 Hill  2005, 
Hill 2010, Rasmussen 2011) or mice’s (De Chiara 2010,Doubreuc 2013, Ferreira-Viera 2014, 
Keeney 2012, Smith  2010).  More specifically in one study mice were mutant (Doubreuc 
2013) while in other study part of the mice were from high runner line  (Keeney 2012), finally 
in two study rat groups were obese or lean (Smith 2010, Rasmussen 2011) 
Study designs varied widely between studies. However all the study designs were somehow 
connected to CB1 receptors (Hill 2005, De Chiara 2010, Keeney 2012 Doubreuc 2013) 
endocannabinoid system (Gomez da Silva  2010, Hill 2010, Galdiano 2014, Ferreira-Viera 
2014), or rewarding properties (Hill 2010, Rasmussen 2011) of endocannabinoid system. Four 
of the studies concentrated on voluntary exercise linked to endocannabinoid system and CB 1 
receptors (Hill 2010, Smith 2010, Rasmussen 2011, Keeney 2012), however one of these 
elucidate whether naloxone and rimonabant may also reduce rewarding properties (Rasmussen 
2011). Rest of the studies had own study design viewpoints such as CB1 receptors mutations 
and of CB1 receptor blockade on wheel-running performance (Doubreuc 2013), whether 
running wheel or sucrose consumption altered the sensitivity of striatal synapses to the 
activation of cannabinoid CB1 receptors (De Chiara 2010) or CB1 expression in the brain of 
rats trained during the adolescent period (Gomez da Silva 2010) as well as assessment if 
enhanced activity at the CB1 receptor elicits antidepressant-like effects (Hill 2005). Finally, 
two remaining studies approached endocannabinoid system from a viewpoint of the memory-
enhancement promoted by physical exercise (Ferreira-Viera 2014) or the mechanisms 
involved in the exercise-induced antinociception (Galdiano 2014).  
Animal research study protocols were mostly a combination of treadmill running and drug 
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adminstration. Eight out of ten protocols included wheel running as “exercise” protocol (Hill 
2010, De Chiara 2010, Gomez da Silva 2010, Rasmussen 2011, Keeney 2012, Doubreuc 2013, 
Galdiano 2014, Ferreira-Viera 2014), one studyused motorized treadmill (Ferreira-Viera 
2014)in one study forced swim test was used in combination with drugs administration (Hill 
2005). Moreover all but one treadmill protocol (Gomez da Silva 2010) included drug 
adminstration as a part of protocol.  Drugs used in protocols were in most studies CB1 
receptor antagonist for e.g. AM251 (Hill 2005, Hill 2010, De Chiara 2010, Ferreira-Viera 
2014, Galdiano 2014), rimonabants (Rasmussen 2011, Doubreuc 2013,) or CB1 agonist 
HU201 (Hill 2005, De Chiara 2010) and 55,212-2 (WIN) (Keeney 2012). In two studies 
subjects were also given Fatty Acid Amide Hydrolase inhibitors (Ferreira-Viera 2014, 
Galdiano 2014).  One protocol also included succarose preference test (succarose water vs 
standard water), open field test and psychoemotional stress and behaviour tests (De Chiara 
2010) while other tested locomotor activity (Doubreuc 2013) rest of the treadmill protocols 
were different combinations of running time, running periods, intensity.  Totally, protocol 
intervention time varied from 1 day (De Chiara 2010) to 36 days (Keeney 2012) 
In animal researches study results varied greater than in human researches due to multiform 
research objects. However all the researches concentrated on CB1 repetors/signalling and 
endocannabinoids from different viewpoints. 
One study stated that mutant mice lacking CB1 receptors from the whole body displayed low 
running activity, compared with wild-type mice, CB1 receptor antagonist rimonabant to wild-
type mice mimicked the negative impact of the CB1 receptor mutation. Rimonabant also 
decreased wheel running, however, rimonabant administration to mice housed in cages 
equipped with activity detectors did not affect locomotor activity (Doubreuc 2013). 
Nevertheless it was also postulatedthat cannabinoid CB1 receptor-mediated presynaptic 
control of striatal inhibitory postsynaptic currents was remarkably potentiated after 
environmental manipulations such as succarose preference, open field and psychoemotional 
stress and behaviour  tests. In addition upregulation of cannabinoid transmission induced by 
wheel running or sucrose had a crucial role in the protective effects of these environmental 
manipulations against the motor and synaptic consequences of stress (De Chiara 2010). 
It was also studied that the physical exercise was able to promote an increase in CB1 receptor 
expression in the hippocampus. Moreover, treatment with FAAH inhibitor, which was able to 
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mimic the behavioural effects of exercise, promoted a similar effect in sedentary animals. 
Accordingly, the effects of exercise were prevented in animals treated with the CB1 antagonist 
and the exercise induced an increase in BDNF expression in the hippocampus of animals 
(Ferreira-Viera 2014), as well as, increase of activation and expression of CB1 receptors in 
neurons of the periaqueductal gray (PAG) after exercise (Galdiano 2014). Finally it was also 
stated that drugs reduce the reinforcing properties of wheel running, but do so in different 
manners: naloxone may suppress wheel-based activity (consummatory behaviour), but not 
seeking (appetitive behaviour), and rimonabant does the converse. Endocannabinoids 
reinforces properties of exercise (Rasmussen 2011).  
Running wheel was also studied to demonstrate increased the agonist binding site density of 
the cannabinoid CB1 receptor. In addition voluntary exercise increased proliferation of 
progenitor cells, as evidenced by the increase in the number of Ki-67 (protein that in humans 
is encoded by the MKI67 gene) positive cells in the granule cell layer of the dentate gyrus 
(DG) in the hippocampus. This effect was abrogated by concurrent treatment with AM251 
(selective CB1 receptor antagonist) (Hill 2010). However in another study which concentrated 
on gender differences states found out that injection of CB1 agonist (WIN) decreased wheel 
revolutions in all mice, but male high runner line mice decreased their running to a greater 
degrees which indicates that male and female HR mice differ from one another in CB1 
signalling as it relates to wheel running (Keeney 2012). 
Few studies compered endocannabinoid activity and exercise with the context of obese rats or 
adolescence of rats. In these studies results suggested that obese rats exhibited lower 
breakpoints for wheel activity, lower response rates and fewer revolutions compared with lean 
rats. As well as 2-AG decreased breakpoints, response rates, and revolutions for obese rats, 
and revolutions only for lean rats. (Smith 2010). Whereas aerobic exercise program performed 
during adolescence significantly reduced the CB1 receptor expression in the striatum and 
hippocampal formation (Gomez da Silva 2010). Finally a study that was conducted by forced 
swim test claims that desipramine (a positive antidepressant control) reduced immobility 
duration by about 50% and that all of AM404 (endocannabinoid uptake inhibitor), oleamide 
(which elicits cannabinoidergic actions) and HU-210 (a potent CB1 receptor agonist) 
administration induced comparable decreases in immobility that were blocked by pre-
treatment with AM 251 (selective CB1 receptor antagonist). Administration of the antagonist 
AM 251 alone had no effect on immobility at either doses (Hill 2005) 
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7 FINDIGNS 
 
The aim of this systematic literature review was to examine how exercise with different types  
influence activation of endocannabinoid system. Viewpoints and results were collected from 
the previous human and animal researches which focused on this field. Sixteen of these 
articles met the inclusion criteria. Most of the studies reviewed indicted that exercise increased 
statistically significantly levels of endocannabinoid anandamide (AEA) during exercise 
regardless of exercise protocol or method. However, most of the findings between human and 
animal studies were somewhat dissimilar and disparate due to rather unique research 
protocols. Consequently findings are more relevant to introduce in two separate sections. 
In human studies it was discovered that exercise increased the levels of AEA during and after 
the exercise regardless of exercise protocol. It was also noted that very high and very low 
intensity exercises increases circulating eCB levels but moderate exercise intensities lead to 
most significant changes in levels of AEA. Levels of endocannabinoid 2-AG shows no 
remarkable changes following or during exercise regardless the intensity level. In addition, 
physical exercise in combination with high altitude enhances activation of the 
endocannabinoid system as well as BDNF (Brain-Derived Neurotrophic Factor) levels, which 
increase significantly during exercise and then decreased during recovery. AEA and BDNF 
concentrations were positively correlated with each other at the end of exercise and after 
recovery. Finally cross-sectional study of human and animal research stated that cursorial 
mammals in general shows significant increase in AEA levels following exercise as non-
cursorial mammals showed no change. 
In animal investigation results were more fragmented compared to human researches. On the 
other hand, number of selected  articles were more extensive as well as studies designs and 
objectives had more dispersion. However animal research findings suggests that physical 
exercise was able to promote an increase in CB1 receptor expression in hippocampus whereas 
endocannabinoids reinforces properties of exercise. This derived partly from the discovery that 
lacking CB1 receptors displayed low running activity in test animals. In addition drugs reduce 
the reinforcing properties of exercise whereas antagonist increased the agonist binding site 
density of the cannabinoid CB1 receptor and mimicked the impact of missing CB1 receptor. 
Animal researches also discovered that cannabinoid transmission had a crucial role in the 
protective effects against the motor and synaptic consequences of stress. In addition CB1 
signalling between male and female HR (high runner) as well as obese rats compared with 
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lean rats differ from one another with lower response rates in male and obese animals. Finally 
adolescence significantly reduced the CB1 receptor expression. 
There were also some limitations of the studies, which should take into account. Firstly, 
comparison between human and animal researches was rather challenging due to different 
research methods, approaches and results. Secondly in human researches there were somewhat 
small sample sizes as well as almost all research subjects were well trained or athletes and 
represents narrow age cohort. Finally in animal researches multiple different drugs and 
different experimental designs were used which obviously weakens the comparability.  
This systematic review includes 10 articles that were not included in the previous systematic 
review on the topic. In addition, previous systematic review was about the role of the 
endocannabinoid system from the viewpoint of implications for the treatment of obesity 
(Heyman 2012) and had somewhat different approach and object to endocannabinoid system. 
Thus this study enhance the understanding of linkage between exercise and endocannabinoid 
system. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
‘ 
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8 CONCLUSION 
 
This systematic review states that exercise activates the endocannabinoid system in humans 
and other mammals (significantly on moderate exercise intensity), suggesting 
endocannabinoids are partly responsible for the reported improvements in mood and affect 
following aerobic exercise and may have important peripheral effects that likely aid exercise 
performance. 
Future studies should focus more on the exercise performance and motivational aspects on 
endocannabinoids and exercise. With richer concept on phenomena and positive effects related 
it could be even possible  motivate people to exercise in order to benefit psychological state, 
pain management, and overall cognitive health (Raichel 2012).   
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